Realm Therapeutics to be acquired by ESSA Pharma
MALVERN: Realm Therapeutics plc has reached agreement with ESSA Pharma Inc. whereby the entire issued and outstanding share capital of Realm will be acquired by ESSA.The acquisition, which is subject…
Realm completes assets disposal for US $10 million
MALVERN: Realm Therapeutics plc has announced the completion of its previously announced assets disposal representing certain assets, which comprise the Vashe wound care royalty stream, an FDA 510(k)-cleared anti-itch hydrogel,…